Aimed Alliance Releases New Maps on Biomarker Testing
On May 10, 2022, Aimed Alliance launched two new maps to track active and enacted…
Browsing: State
FDA Asks Congress for New Authority To Regulate CBD
When addressing the Food and Drug Administration’s (FDA) reluctancy to develop new regulations for cannabidiol…
The White House and Federal Agencies Focus on Addressing Long COVID
Some patients that have recovered from a COVID-19 infection experience what the CDC has termed…
Aimed Alliance Speaks at HealthyWomen’s Cures 2.0 Virtual Policy Discussion
On May 11, 2022, Aimed Alliance’s staff attorney, Ashira Vantrees, participated as a panelist on…
AHIP Pushes Back on HHS Efforts To Ensure Non-Discrimination in Plan Design
In its 2023 Notice of Benefit and Payment Parameters Proposed Rule (2023 NBPP), the U.S.…
Food and Drug Administration Issues Guidance on Race and Ethnicity Diversity Plans for Clinical Trials
On April 13, the Food and Drug Administration published a draft guidance on “Diversity Plans…
Michigan Expands Postpartum Coverage for Up To 12 Months
On April 14, 2022, Michigan joined a growing number of states that can now offer…
White House Proposes to Fix “Family Glitch” in the ACA
On April 5, 2022, the Biden Administration announced that the Treasury Department and the Internal…
Aimed Alliance Sends Letter of Support to Minnesota Legislature on Copay Accumulator Reform
On March 25, 2022, Aimed Alliance sent a letter to the Minnesota House of Representatives…
Aimed Alliance Hosts Webinar on Covering Prescription Digital Therapeutics: A Win-Win for Employers and Employees
On March 29, 2022, Aimed Alliance hosted a webinar through HR.com titled “Covering Prescription Digital…